Lymphoma Survivor Takes Up Lifetime TV’s Challenge

Trina Pockett was pregnant and living in Southern California when she went in to the doctor to find out whether she was having a boy or a girl. You’re having a girl, they told her. Oh, and by the way, you also have Stage 3 Hodgkin’s lymphoma.



OK, they didn’t say it that rudely. Rather, she mentioned a lump in her neck, which when biopsied was confirmed for Hodgkin’s lymphoma. The cancer was in Stage 3 because being pregnant made noticing her cancer symptoms and seperating them from pregnancy much more difficult.



At 5 and a half months pregnant she began a rigorous 2 months of chemotherapy. She was induced 6 weeks earlier than her due date and gave birth to a healthy baby girl who weighed 4 lbs 8 ozs.



The experience has drastically changed her, and it prompted her to write in to Lifetime Television’s Clean State Challenge 2009. The Clean Slate Challenge is a contest by the channel that encourages women to take part in a life-changing experience in 2009.



For her part Pockett, not a runner by trade or hobby, will participate in the Leukemia and Lymphoma Society's Team in Training half marathon in San Diego on May 31, 2009.



You can see a video of Trina Pockett here, at Lifetime’s website.

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap